Literature DB >> 11154622

Second dose of measles, mumps, and rubella vaccine: questionnaire survey of health professionals.

M Petrovic1, R Roberts, M Ramsay.   

Abstract

OBJECTIVE: To determine the knowledge, attitudes, and practices among health professionals regarding the measles, mumps, and rubella (MMR) vaccine, particularly the second dose.
DESIGN: Self administered postal questionnaire survey.
SETTING: North Wales Health Authority, 1998. PARTICIPANTS: 148 health visitors, 239 practice nurses, and 206 general practitioners. MAIN OUTCOME MEASURES: Respondents' views on MMR vaccination, including their views on the likelihood of an association with autism and Crohn's disease and on who is the best person to give advice to parents, whether they agree with the policy of a second dose of the vaccine, and how confident they are in explaining the rationale behind the second dose.
RESULTS: Concerning the second dose of the vaccine, 48% of the professionals (220/460) had reservations and 3% (15) disagreed with the policy of giving it. Over half the professionals nominated health visitors as the best initial source of advice on the second vaccine. 61% of health visitors (86/140), compared with 46% of general practitioners (73/158), reported feeling very confident about explaining the rationale of a two dose schedule to a well informed parent, but only 20% (28/138) would unequivocally recommend the second dose to a wavering parent. 33% of the practice nurses (54/163) stated that the MMR vaccine was very likely or possibly associated with Crohn's disease and 27% (44/164) that it was associated with autism. Nearly a fifth of general practitioners (27/158) reported that they had not read the MMR section in the "green book," and 29% (44/152) reported that they had not received the Health Education Authority's factsheet on MMR immunisation.
CONCLUSIONS: Knowledge and practice among health professionals regarding the second dose of the MMR vaccine vary widely. Many professionals are not aware of or do not use the good written resources that exist, though local educational initiatives could remedy this.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11154622      PMCID: PMC26597          DOI: 10.1136/bmj.322.7278.82

Source DB:  PubMed          Journal:  BMJ        ISSN: 0959-8138


  10 in total

1.  Health 21: The health for all policy framework for the WHO European Region.

Authors: 
Journal:  J Adv Nurs       Date:  1999-08       Impact factor: 3.187

2.  Interpretation of serological surveillance data for measles using mathematical models: implications for vaccine strategy.

Authors:  N J Gay; L M Hesketh; P Morgan-Capner; E Miller
Journal:  Epidemiol Infect       Date:  1995-08       Impact factor: 2.451

3.  Vaccine adverse events: causal or coincidental?

Authors:  R T Chen; F DeStefano
Journal:  Lancet       Date:  1998-02-28       Impact factor: 79.321

4.  A second dose of MMR vaccine for children in the United Kingdom.

Authors: 
Journal:  Commun Dis Rep CDR Wkly       Date:  1996-07-26

Review 5.  Successes and failures in measles control.

Authors:  F T Cutts; L E Markowitz
Journal:  J Infect Dis       Date:  1994-11       Impact factor: 5.226

6.  Autism and measles, mumps, and rubella vaccine: no epidemiological evidence for a causal association.

Authors:  B Taylor; E Miller; C P Farrington; M C Petropoulos; I Favot-Mayaud; J Li; P A Waight
Journal:  Lancet       Date:  1999-06-12       Impact factor: 79.321

7.  Ileal-lymphoid-nodular hyperplasia, non-specific colitis, and pervasive developmental disorder in children.

Authors:  A J Wakefield; S H Murch; A Anthony; J Linnell; D M Casson; M Malik; M Berelowitz; A P Dhillon; M A Thomson; P Harvey; A Valentine; S E Davies; J A Walker-Smith
Journal:  Lancet       Date:  1998-02-28       Impact factor: 79.321

8.  The elimination of indigenous measles, mumps, and rubella from Finland by a 12-year, two-dose vaccination program.

Authors:  H Peltola; O P Heinonen; M Valle; M Paunio; M Virtanen; V Karanko; K Cantell
Journal:  N Engl J Med       Date:  1994-11-24       Impact factor: 91.245

9.  A new method for active surveillance of adverse events from diphtheria/tetanus/pertussis and measles/mumps/rubella vaccines.

Authors:  P Farrington; S Pugh; A Colville; A Flower; J Nash; P Morgan-Capner; M Rush; E Miller
Journal:  Lancet       Date:  1995-03-04       Impact factor: 79.321

10.  Advances in global measles control and elimination: summary of the 1997 international meeting.

Authors: 
Journal:  MMWR Recomm Rep       Date:  1998-07-24
  10 in total
  19 in total

1.  MMR vaccine: the continuing saga.

Authors:  D Elliman; H Bedford
Journal:  BMJ       Date:  2001-01-27

Review 2.  Ethical debate: Vaccination against mumps, measles, and rubella: is there a case for deepening the debate? How safe is MMR vaccine?

Authors:  T Heller
Journal:  BMJ       Date:  2001-10-13

3.  Health professionals' attitudes to MMR vaccine. "Green book" should be updated every six months.

Authors:  J Howell; H Duggal; K Howell
Journal:  BMJ       Date:  2001-05-05

4.  Communication and miscommunication of risk: understanding UK parents' attitudes to combined MMR vaccination.

Authors:  Paul Bellaby
Journal:  BMJ       Date:  2003-09-27

5.  [Portrait of the formation in vaccination training offered to Quebec nurses in the workplace].

Authors:  Chantal Sauvageau; Nicole Boulianne; Anne-Marie Clouâtre; France Lavoie; Bernard Duval
Journal:  Can J Public Health       Date:  2005 Jul-Aug

Review 6.  MMR: where are we now?

Authors:  David Elliman; Helen Bedford
Journal:  Arch Dis Child       Date:  2007-07-11       Impact factor: 3.791

7.  Target the fence-sitters.

Authors:  Julie Leask
Journal:  Nature       Date:  2011-05-26       Impact factor: 49.962

8.  Parental confidence in measles, mumps and rubella vaccine: evidence from vaccine coverage and attitudinal surveys.

Authors:  Mary E Ramsay; J Yarwood; D Lewis; H Campbell; J M White
Journal:  Br J Gen Pract       Date:  2002-11       Impact factor: 5.386

9.  Parents' perspectives on the MMR immunisation: a focus group study.

Authors:  M Evans; H Stoddart; L Condon; E Freeman; M Grizzell; R Mullen
Journal:  Br J Gen Pract       Date:  2001-11       Impact factor: 5.386

10.  Managing controversy through consultation: a qualitative study of communication and trust around MMR vaccination decisions.

Authors:  Robert McMurray; Francine M Cheater; Anna Weighall; Carolyn Nelson; Martin Schweiger; Suzanne Mukherjee
Journal:  Br J Gen Pract       Date:  2004-07       Impact factor: 5.386

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.